Researchers compared the PSA intensity of the overall testes and the transition zone in patient populations with benign prostatic hyperplasia (BPH) and prostate cancer that had a serum PSA compared with fewer than 10 ng/ml. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.